目次

TABLE OF CONTENTS

1 INTRODUCTION (Page No. - 28)
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS AND EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 REGIONS COVERED
1.4 YEARS CONSIDERED
1.5 CURRENCY CONSIDERED
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES
1.8 IMPACT OF RECESSION: BLOOD CULTURE TESTS MARKET

2 RESEARCH METHODOLOGY (Page No. - 34)
2.1 RESEARCH APPROACH
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Key data from primary sources
2.1.2.2 Insights from primary experts
2.2 MARKET SIZE ESTIMATION
2.3 APPROACH TO DETERMINE IMPACT OF ECONOMIC RECESSION
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
2.5 MARKET SHARE ANALYSIS
2.6 STUDY ASSUMPTIONS
2.7 RESEARCH LIMITATIONS
2.7.1 METHODOLOGY-RELATED LIMITATIONS
2.7.2 SCOPE-RELATED LIMITATIONS
2.8 RISK ASSESSMENT

3 EXECUTIVE SUMMARY (Page No. - 46)

4 PREMIUM INSIGHTS (Page No. - 51)
4.1 BLOOD CULTURE TESTS MARKET OVERVIEW
4.2 BLOOD CULTURE TESTS MARKET, BY PRODUCT
4.3 ASIA PACIFIC: BLOOD CULTURE TESTS MARKET, BY METHOD AND COUNTRY (2022)
4.4 BLOOD CULTURE TESTS MARKET: REGIONAL MIX
4.5 BLOOD CULTURE TESTS MARKET: DEVELOPED VS. EMERGING ECONOMIES

5 MARKET OVERVIEW (Page No. - 56)
5.1 INTRODUCTION
5.1.1 DRIVERS
5.1.1.1 Increasing number of sepsis patients and rising cost of treatment
5.1.1.2 Rapid growth in geriatric population with chronic diseases
5.1.1.3 High incidence of nosocomial bloodstream infections
5.1.1.4 Growing demand for rapid diagnostic techniques with faster turnaround times
5.1.1.5 High prevalence of infectious diseases globally
5.1.2 RESTRAINTS
5.1.2.1 High cost of automated blood culture instruments
5.1.2.2 Lack of trained laboratory technicians
5.1.3 OPPORTUNITIES
5.1.3.1 Growth opportunities in emerging economies
5.1.3.2 Increased need to identify antibiotic-resistant microorganisms
5.1.4 CHALLENGES
5.1.4.1 Market cannibalization for conventional products
5.1.4.2 Difficulty in survival of new entrants
5.2 INDUSTRY TRENDS
5.2.1 LABORATORY AUTOMATION FOR INCREASED EFFICIENCY AND ACCURATE DIAGNOSIS
5.2.2 FOCUS ON ANTIMICROBIAL STEWARDSHIP
5.3 TECHNOLOGY ANALYSIS
5.3.1 ADVANCED FLUORESCENCE DETECTION TECHNOLOGY
5.4 AVERAGE SELLING PRICE, BY TYPE
5.4.1 AVERAGE SELLING PRICE FOR BLOOD CULTURE TEST PRODUCTS, BY KEY PLAYER (2022)
5.5 VALUE CHAIN ANALYSIS
5.6 SUPPLY CHAIN ANALYSIS
5.7 ECOSYSTEM MAPPING
5.8 PORTER’S FIVE FORCES ANALYSIS
5.8.1 THREAT OF NEW ENTRANTS
5.8.2 THREAT OF SUBSTITUTES
5.8.3 BARGAINING POWER OF BUYERS
5.8.4 BARGAINING POWER OF SUPPLIERS
5.8.5 INTENSITY OF COMPETITIVE RIVALRY
5.9 TARIFF AND REGULATORY ANALYSIS
5.9.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.9.2 REGULATORY ANALYSIS
5.9.2.1 North America
5.9.2.1.1 US
5.9.2.1.2 Canada
5.9.2.2 Europe
5.9.3 ASIA PACIFIC
5.9.3.1 Japan
5.9.3.2 China
5.9.3.3 India
5.10 PATENT ANALYSIS
5.10.1 PATENT PUBLICATION TRENDS FOR BLOOD CULTURE TESTS MARKET
5.10.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
5.11 KEY CONFERENCES AND EVENTS IN 2023-2024
5.12 KEY STAKEHOLDERS AND BUYING CRITERIA
5.12.1 KEY STAKEHOLDERS IN BUYING PROCESS
5.12.2 BUYING CRITERIA

6 BLOOD CULTURE TESTS MARKET, BY METHOD (Page No. - 79)
6.1 INTRODUCTION
6.2 CONVENTIONAL/MANUAL BLOOD CULTURE
6.2.1 CONVENTIONAL/MANUAL BLOOD CULTURE METHOD TO ACCOUNT FOR LARGER SHARE OF BLOOD CULTURE TESTS MARKET
6.3 AUTOMATED BLOOD CULTURE
6.3.1 INCREASED R&D INVESTMENTS BY MANUFACTURERS FOR DEVELOPING NOVEL PRODUCTS TO DRIVE MARKET

7 BLOOD CULTURE TESTS MARKET, BY PRODUCT (Page No. - 85)
7.1 INTRODUCTION
7.2 CONSUMABLES
7.2.1 BLOOD CULTURE MEDIA
7.2.1.1 Aerobic blood culture media
7.2.1.1.1 Aerobic blood culture media to be fastest-growing segment of blood culture media market during forecast period
7.2.1.2 Pediatric aerobic blood culture media
7.2.1.2.1 Increased need to recover pathogens from bloodstream of children to drive segment
7.2.1.3 Anaerobic blood culture media
7.2.1.3.1 Increased need for routine diagnosis of bacteria in blood culture to drive segment
7.2.1.4 Mycobacterial blood culture media
7.2.1.4.1 Rising prevalence of tuberculosis to drive segment
7.2.1.5 Fungi/yeast blood culture media
7.2.1.5.1 Easy identification and characterization of special fungal species to drive segment
7.2.2 ASSAY KITS & REAGENTS
7.2.2.1 Increased need for rapid identification of bacteria and yeast from positive blood cultures to drive market
7.2.3 BLOOD CULTURE ACCESSORIES
7.2.3.1 Growing number of blood culture tests to drive market
7.3 INSTRUMENTS
7.3.1 AUTOMATED BLOOD CULTURE SYSTEMS
7.3.1.1 Need for automated imaging systems and advanced algorithms to drive market
7.3.2 SUPPORTING LABORATORY EQUIPMENT
7.3.2.1 Incubators
7.3.2.1.1 Incubators to provide optimal environment with adequate temperature and oxygen levels for microbial growth
7.3.2.2 Colony counters
7.3.2.2.1 Colony counters to increase direct image scanning and analysis capability
7.3.2.3 Microscopes
7.3.2.3.1 Favorable funding scenario for R&D and technological advancements to drive segment
7.3.2.4 Gram stainers
7.3.2.4.1 Gram strainers to guide initial antibiotic section and appropriate empirical therapy
7.4 SOFTWARE & SERVICES
7.4.1 INCREASED NEED FOR AUTOMATED SYSTEMS IN HOSPITAL-BASED LABORATORIES TO DRIVE MARKET

8 BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY (Page No. - 107)
8.1 INTRODUCTION
8.2 CULTURE-BASED TECHNOLOGIES
8.2.1 DRAWBACKS ASSOCIATED WITH TRADITIONAL CULTURE-BASED TECHNOLOGIES TO LIMIT MARKET
8.3 TOP OF FORM
8.3.1 MOLECULAR TECHNOLOGIES
8.3.2 MICROARRAYS
8.3.2.1 Determination of better genotyping characterization and identification of bacterial infections to drive segment
8.3.3 PCR
8.3.3.1 Reduced risk of contaminations and easy detection of bloodstream infections to drive segment
8.3.4 PNA-FISH
8.3.4.1 PNA-FISH to use genetic markers for analysis of pathogens directly from whole blood samples
8.4 PROTEOMICS
8.4.1 PROTEOMICS TO CONTROL INFECTIOUS DISEASES AND ANALYZE COMPLEX MICROBIAL SYSTEMS WITHIN HUMAN FLUIDS

9 BLOOD CULTURE TESTS MARKET, BY APPLICATION (Page No. - 118)
9.1 INTRODUCTION
9.2 BACTEREMIA
9.2.1 GROWING INCIDENCE OF SEPSIS CASES GLOBALLY TO DRIVE MARKET
9.3 FUNGEMIA
9.3.1 INCREASING INCIDENCE OF BLOODSTREAM INFECTIONS TO DRIVE MARKET
9.4 MYCOBACTERIAL DETECTION
9.4.1 RISING GERIATRIC POPULATION WITH TUBERCULOSIS TO DRIVE MARKET

10 BLOOD CULTURE TESTS MARKET, BY END USER (Page No. - 123)
10.1 INTRODUCTION
10.2 HOSPITAL LABORATORIES
10.2.1 INCREASED ABILITY TO CONDUCT LARGE VOLUME OF BLOOD CULTURE TESTS TO DRIVE MARKET
10.3 REFERENCE LABORATORIES
10.3.1 INCREASING REQUIREMENT OF ROUTINE AND SPECIALTY TESTS TO DRIVE MARKET
10.4 ACADEMIC RESEARCH LABORATORIES
10.4.1 INCREASING FOCUS ON R&D OF INNOVATIVE TESTS FOR BLOODSTREAM INFECTIONS TO DRIVE MARKET
10.5 OTHER LABORATORIES

11 BLOOD CULTURE TESTS MARKET, BY REGION (Page No. - 131)
11.1 INTRODUCTION
11.2 NORTH AMERICA
11.2.1 US
11.2.1.1 US to dominate blood culture tests market during study period
11.2.2 CANADA
11.2.2.1 Increasing incidence of bloodstream infections to drive market
11.2.3 NORTH AMERICA: RECESSION IMPACT
11.3 EUROPE
11.3.1 GERMANY
11.3.1.1 Germany commanded largest share of European blood culture tests market in 2022
11.3.2 UK
11.3.2.1 High burden of sepsis and increased geriatric population to drive market
11.3.3 FRANCE
11.3.3.1 Rising geriatric population and favorable government regulations to drive market
11.3.4 ITALY
11.3.4.1 Slow growth in healthcare sector with increased health expenditure to limit market
11.3.5 SPAIN
11.3.5.1 Rapid increase in diagnostic procedures and improved healthcare infrastructure to drive market
11.3.6 REST OF EUROPE
11.3.7 EUROPE: RECESSION IMPACT
11.4 ASIA PACIFIC
11.4.1 JAPAN
11.4.1.1 Japan to be largest market for blood culture tests in Asia Pacific
11.4.2 CHINA
11.4.2.1 Rapid economic growth and rising disposable income of middle-class population to drive market
11.4.3 INDIA
11.4.3.1 Rising prevalence of infectious diseases and growing geriatric population to drive market
11.4.4 REST OF ASIA PACIFIC
11.4.5 ASIA PACIFIC: RECESSION IMPACT
11.5 LATIN AMERICA
11.5.1 FAVORABLE GOVERNMENT INITIATIVES TO DRIVE MARKET
11.5.2 LATIN AMERICA: RECESSION IMPACT
11.6 MIDDLE EAST & AFRICA
11.6.1 INFRASTRUCTURAL DEVELOPMENTS AND ADVANCED HEALTHCARE FACILITIES TO DRIVE MARKET
11.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT

12 COMPETITIVE LANDSCAPE (Page No. - 202)
12.1 MARKET OVERVIEW
12.2 REVENUE SHARE ANALYSIS OF KEY MARKET PLAYERS
12.3 MARKET SHARE ANALYSIS
12.4 COMPANY EVALUATION MATRIX FOR KEY PLAYERS
12.4.1 STARS
12.4.2 EMERGING LEADERS
12.4.3 PERVASIVE PLAYERS
12.4.4 PARTICIPANTS
12.5 COMPANY EVALUATION MATRIX FOR START-UPS/SMES (2022)
12.5.1 PROGRESSIVE COMPANIES
12.5.2 STARTING BLOCKS
12.5.3 RESPONSIVE COMPANIES
12.5.4 DYNAMIC COMPANIES
12.6 COMPANY FOOTPRINT
12.6.1 METHOD FOOTPRINT
12.6.2 PRODUCT FOOTPRINT
12.6.3 TECHNOLOGY FOOTPRINT
12.6.4 APPLICATION FOOTPRINT
12.6.5 END USER FOOTPRINT
12.6.6 REGIONAL FOOTPRINT
12.7 COMPETITIVE SITUATION AND TRENDS
12.7.1 KEY PRODUCT LAUNCHES AND APPROVALS
12.7.2 KEY DEALS

13 COMPANY PROFILES (Page No. - 222)
13.1 KEY PLAYERS
13.1.1 BECTON, DICKINSON AND COMPANY
13.1.1.1 Business overview
13.1.1.2 Products offered
13.1.1.3 Recent developments
13.1.1.4 MnM view
13.1.1.4.1 Right to win
13.1.1.4.2 Strategic choices
13.1.1.4.3 Weaknesses and competitive threats
13.1.2 BIOMÉRIEUX
13.1.2.1 Business overview
13.1.2.2 Products offered
13.1.2.3 Recent developments
13.1.2.4 MnM view
13.1.2.4.1 Right to win
13.1.2.4.2 Strategic choices
13.1.2.4.3 Weaknesses and competitive threats
13.1.3 THERMO FISHER SCIENTIFIC INC.
13.1.3.1 Business overview
13.1.3.2 Products offered
13.1.3.3 MnM view
13.1.3.3.1 Right to win
13.1.3.3.2 Strategic choices
13.1.3.3.3 Weaknesses and competitive threats
13.1.4 DANAHER
13.1.4.1 Business overview
13.1.4.2 Products offered
13.1.4.3 Recent developments
13.1.4.4 MnM view
13.1.4.4.1 Right to win
13.1.4.4.2 Strategic choices
13.1.4.4.3 Weaknesses and competitive threats
13.1.5 LUMINEX CORPORATION
13.1.5.1 Business overview
13.1.5.2 Products offered
13.1.5.3 Recent developments
13.1.5.4 MnM view
13.1.5.4.1 Right to win
13.1.5.4.2 Strategic choices
13.1.5.4.3 Weaknesses and competitive threats
13.1.6 BRUKER
13.1.6.1 Business overview
13.1.6.2 Products offered
13.1.6.3 Recent developments
13.1.7 ROCHE DIAGNOSTICS
13.1.7.1 Business overview
13.1.7.2 Products offered
13.1.7.3 Recent developments
13.1.8 IRIDICA
13.1.8.1 Business overview
13.1.8.2 Products offered
13.1.9 T2 BIOSYSTEMS, INC.
13.1.9.1 Business overview
13.1.9.2 Products offered
13.1.9.3 Recent developments
13.1.10 BINDER GMBH
13.1.10.1 Business overview
13.1.10.2 Products offered
13.1.11 BIOBASE BIOTECH (JINAN) CO., LTD.
13.1.11.1 Business overview
13.1.11.2 Products offered
13.1.12 SCENKER BIOLOGICAL TECHNOLOGY CO., LTD.
13.1.12.1 Business overview
13.1.12.2 Products offered
13.1.13 BULLDOG BIO
13.1.13.1 Business overview
13.1.13.2 Products offered
13.1.14 ANAEROBE SYSTEMS, INC.
13.1.14.1 Business overview
13.1.14.2 Products offered
13.1.15 HIMEDIA LABORATORIES PVT. LTD.
13.1.15.1 Business overview
13.1.15.2 Products offered
13.1.16 AUTOBIO DIAGNOSTICS CO., LTD.
13.1.16.1 Business overview
13.1.16.2 Products offered
13.1.17 AXIOM LABORATORIES
13.1.17.1 Business overview
13.1.17.2 Products offered
13.1.18 MIKROSCAN TECHNOLOGIES, INC.
13.1.18.1 Business overview
13.1.18.2 Products offered
13.1.18.3 Recent developments
13.1.19 LABOTRONICS LTD.
13.1.19.1 Business overview
13.1.19.2 Products offered
13.1.20 HARDY DIAGNOSTICS
13.1.20.1 Business overview
13.1.20.2 Products offered
13.2 OTHER PLAYERS
13.2.1 OPGEN, INC.
13.2.2 MEDITECH TECHNOLOGIES INDIA PRIVATE LIMITED
13.2.3 CARL ZEISS AG
13.2.4 NIKON CORPORATION
13.2.5 TERUMO CORPORATION

14 APPENDIX (Page No. - 268)
14.1 DISCUSSION GUIDE
14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
14.3 CUSTOMIZATION OPTIONS
14.4 RELATED REPORTS
14.5 AUTHOR DETAILS

LIST OF TABLES (269 TABLES)
TABLE 1 STANDARD CURRENCY CONVERSION RATES
TABLE 2 RISK ASSESSMENT: BLOOD CULTURE TESTS MARKET
TABLE 3 US: FIVE MOST EXPENSIVE CONDITIONS TREATED IN HOSPITALS
TABLE 4 GERIATRIC POPULATION: KEY STATISTICS
TABLE 5 REGIONAL PRICING ANALYSIS OF BLOOD CULTURE TEST PRODUCTS, BY TYPE, 2021 (USD)
TABLE 6 PORTER’S FIVE FORCES ANALYSIS: BLOOD CULTURE TESTS MARKET
TABLE 7 LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 8 US FDA: MEDICAL DEVICE CLASSIFICATION
TABLE 9 US: TIME, COST, AND COMPLEXITY OF REGISTRATION
TABLE 10 CANADA: CLASSIFICATION OF PRODUCTS
TABLE 11 CANADA: TIME, COST, AND COMPLEXITY OF REGISTRATION
TABLE 12 EUROPE: ACCREDITATION BODIES FOR MEDICAL LABORATORIES
TABLE 13 BLOOD CULTURE TESTS MARKET: LIST OF PATENTS (2020-2023)
TABLE 14 BLOOD CULTURE TESTS MARKET: DETAILED LIST OF CONFERENCES AND EVENTS IN 2023-2024
TABLE 15 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS IN BLOOD CULTURE TESTS MARKET (%)
TABLE 16 KEY BUYING CRITERIA FOR BLOOD CULTURE TEST METHODS
TABLE 17 BLOOD CULTURE TESTS MARKET, BY METHOD, 2021-2028 (USD MILLION)
TABLE 18 EXAMPLES OF CONVENTIONAL/MANUAL BLOOD CULTURE PRODUCTS
TABLE 19 BLOOD CULTURE TESTS MARKET FOR CONVENTIONAL/MANUAL BLOOD CULTURE, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 20 EXAMPLES OF AUTOMATED BLOOD CULTURE PRODUCTS
TABLE 21 BLOOD CULTURE TESTS MARKET FOR AUTOMATED BLOOD CULTURE, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 22 BLOOD CULTURE TESTS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
TABLE 23 BLOOD CULTURE TESTS MARKET FOR CONSUMABLES, BY TYPE, 2021-2028 (USD MILLION)
TABLE 24 BLOOD CULTURE TESTS MARKET FOR CONSUMABLES, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 25 EXAMPLES OF BLOOD CULTURE MEDIA
TABLE 26 BLOOD CULTURE MEDIA MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 27 BLOOD CULTURE MEDIA MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 28 AEROBIC BLOOD CULTURE MEDIA MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 29 PEDIATRIC AEROBIC BLOOD CULTURE MEDIA MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 30 ANAEROBIC BLOOD CULTURE MEDIA MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 31 MYCOBACTERIAL BLOOD CULTURE MEDIA MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 32 FUNGI/YEAST BLOOD CULTURE MEDIA MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 33 EXAMPLES OF BLOOD CULTURE ASSAY KITS & REAGENTS
TABLE 34 ASSAY KITS & REAGENTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 35 EXAMPLES OF BLOOD CULTURE ACCESSORIES
TABLE 36 BLOOD CULTURE ACCESSORIES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 37 BLOOD CULTURE TESTS MARKET FOR INSTRUMENTS, BY TYPE, 2021-2028 (USD MILLION)
TABLE 38 EXAMPLES OF AUTOMATED BLOOD CULTURE SYSTEMS
TABLE 39 AUTOMATED BLOOD CULTURE SYSTEMS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 40 SUPPORTING LABORATORY EQUIPMENT MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 41 SUPPORTING LABORATORY EQUIPMENT MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 42 INCUBATORS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 43 COLONY COUNTERS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 44 MICROSCOPES MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 45 GARAM STAINERS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 46 BLOOD CULTURE TESTS MARKET FOR SOFTWARE & SERVICES, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 47 BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
TABLE 48 BLOOD CULTURE TESTS MARKET FOR CULTURE-BASED TECHNOLOGIES, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 49 BLOOD CULTURE TESTS MARKET FOR MOLECULAR TECHNOLOGIES, BY TYPE, 2021-2028 (USD MILLION)
TABLE 50 BLOOD CULTURE TESTS MARKET FOR MOLECULAR TECHNOLOGIES, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 51 MICROARRAYS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 52 PCR MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 53 PNA-FISH MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 54 BLOOD CULTURE TESTS MARKET FOR PROTEOMICS, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 55 EXAMPLES OF MALDI-TOF MS SYSTEMS
TABLE 56 BLOOD CULTURE TESTS MARKET, BY APPLICATION, 2021-2028(USD MILLION)
TABLE 57 BLOOD CULTURE TESTS MARKET FOR BACTEREMIA, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 58 BLOOD CULTURE TESTS MARKET FOR FUNGEMIA, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 59 BLOOD CULTURE TESTS MARKET FOR MYCOBACTERIAL DETECTION, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 60 BLOOD CULTURE TESTS MARKET, BY END USER, 2021-2028 (USD MILLION)
TABLE 61 BLOOD CULTURE TESTS MARKET FOR HOSPITAL LABORATORIES, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 62 BLOOD CULTURE TESTS MARKET FOR REFERENCE LABORATORIES, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 63 BLOOD CULTURE TESTS MARKET FOR ACADEMIC RESEARCH LABORATORIES, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 64 BLOOD CULTURE TESTS MARKET FOR OTHER LABORATORIES, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 65 BLOOD CULTURE TESTS MARKET, BY REGION, 2021-2028 (USD MILLION)
TABLE 66 NORTH AMERICA: BLOOD CULTURE TESTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 67 NORTH AMERICA: BLOOD CULTURE TESTS MARKET, BY METHOD, 2021-2028 (USD MILLION)
TABLE 68 NORTH AMERICA: BLOOD CULTURE TESTS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
TABLE 69 NORTH AMERICA: BLOOD CULTURE TESTS MARKET FOR CONSUMABLES, BY TYPE, 2021-2028 (USD MILLION)
TABLE 70 NORTH AMERICA: BLOOD CULTURE MEDIA MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 71 NORTH AMERICA: BLOOD CULTURE TESTS MARKET FOR INSTRUMENTS, BY TYPE, 2021-2028 (USD MILLION)
TABLE 72 NORTH AMERICA: SUPPORTING LABORATORY EQUIPMENT MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 73 NORTH AMERICA: BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
TABLE 74 NORTH AMERICA: BLOOD CULTURE TESTS MARKET FOR MOLECULAR TECHNOLOGIES, BY TYPE, 2021-2028 (USD MILLION)
TABLE 75 NORTH AMERICA: BLOOD CULTURE TESTS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 76 NORTH AMERICA: BLOOD CULTURE TESTS MARKET, BY END USER, 2021-2028 (USD MILLION)
TABLE 77 US: BLOOD CULTURE TESTS MARKET, BY METHOD, 2021-2028 (USD MILLION)
TABLE 78 US: BLOOD CULTURE TESTS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
TABLE 79 US: BLOOD CULTURE TESTS MARKET FOR CONSUMABLES, BY TYPE, 2021-2028 (USD MILLION)
TABLE 80 US: BLOOD CULTURE MEDIA MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 81 US: BLOOD CULTURE TESTS MARKET FOR INSTRUMENTS, BY TYPE, 2021-2028 (USD MILLION)
TABLE 82 US: SUPPORTING LABORATORY EQUIPMENT MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 83 US: BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
TABLE 84 US: BLOOD CULTURE TESTS MARKET FOR MOLECULAR TECHNOLOGIES, BY TYPE, 2021-2028 (USD MILLION)
TABLE 85 US: BLOOD CULTURE TESTS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 86 US: BLOOD CULTURE TESTS MARKET, BY END USER, 2021-2028 (USD MILLION)
TABLE 87 CANADA: BLOOD CULTURE TESTS MARKET, BY METHOD, 2021-2028 (USD MILLION)
TABLE 88 CANADA: BLOOD CULTURE TESTS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
TABLE 89 CANADA: BLOOD CULTURE TESTS MARKET FOR CONSUMABLES, BY TYPE, 2021-2028 (USD MILLION)
TABLE 90 CANADA: BLOOD CULTURE MEDIA MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 91 CANADA: BLOOD CULTURE TESTS MARKET FOR INSTRUMENTS, BY TYPE, 2021-2028 (USD MILLION)
TABLE 92 CANADA: SUPPORTING LABORATORY EQUIPMENT MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 93 CANADA: BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
TABLE 94 CANADA: BLOOD CULTURE TESTS MARKET FOR MOLECULAR TECHNOLOGIES, BY TYPE, 2021-2028 (USD MILLION)
TABLE 95 CANADA: BLOOD CULTURE TESTS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 96 CANADA: BLOOD CULTURE TESTS MARKET, BY END USER, 2021-2028 (USD MILLION)
TABLE 97 EUROPE: BLOOD CULTURE TESTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 98 EUROPE: BLOOD CULTURE TESTS MARKET, BY METHOD, 2021-2028 (USD MILLION)
TABLE 99 EUROPE: BLOOD CULTURE TESTS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
TABLE 100 EUROPE: BLOOD CULTURE TESTS MARKET FOR CONSUMABLES, BY TYPE, 2021-2028 (USD MILLION)
TABLE 101 EUROPE: BLOOD CULTURE MEDIA MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 102 EUROPE: BLOOD CULTURE TESTS MARKET FOR INSTRUMENTS, BY TYPE, 2021-2028 (USD MILLION)
TABLE 103 EUROPE: SUPPORTING LABORATORY EQUIPMENT MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 104 EUROPE: BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
TABLE 105 EUROPE: BLOOD CULTURE TESTS MARKET FOR MOLECULAR TECHNOLOGIES, BY TYPE, 2021-2028 (USD MILLION)
TABLE 106 EUROPE: BLOOD CULTURE TESTS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 107 EUROPE: BLOOD CULTURE TESTS MARKET, BY END USER, 2021-2028 (USD MILLION)
TABLE 108 GERMANY: BLOOD CULTURE TESTS MARKET, BY METHOD, 2021-2028 (USD MILLION)
TABLE 109 GERMANY: BLOOD CULTURE TESTS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
TABLE 110 GERMANY: BLOOD CULTURE TESTS MARKET FOR CONSUMABLES, BY TYPE, 2021-2028 (USD MILLION)
TABLE 111 GERMANY: BLOOD CULTURE MEDIA MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 112 GERMANY: BLOOD CULTURE TESTS MARKET FOR INSTRUMENTS, BY TYPE, 2021-2028 (USD MILLION)
TABLE 113 GERMANY: SUPPORTING LABORATORY EQUIPMENT MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 114 GERMANY: BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
TABLE 115 GERMANY: BLOOD CULTURE TESTS MARKET FOR MOLECULAR TECHNOLOGIES, BY TYPE, 2021-2028 (USD MILLION)
TABLE 116 GERMANY: BLOOD CULTURE TESTS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 117 GERMANY: BLOOD CULTURE TESTS MARKET, BY END USER, 2021-2028 (USD MILLION)
TABLE 118 UK: BLOOD CULTURE TESTS MARKET, BY METHOD, 2021-2028 (USD MILLION)
TABLE 119 UK: BLOOD CULTURE TESTS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
TABLE 120 UK: BLOOD CULTURE TESTS MARKET FOR CONSUMABLES, BY TYPE, 2021-2028 (USD MILLION)
TABLE 121 UK: BLOOD CULTURE MEDIA MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 122 UK: BLOOD CULTURE TESTS MARKET FOR INSTRUMENTS, BY TYPE, 2021-2028 (USD MILLION)
TABLE 123 UK: SUPPORTING LABORATORY EQUIPMENT MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 124 UK: BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
TABLE 125 UK: BLOOD CULTURE TESTS MARKET FOR MOLECULAR TECHNOLOGIES, BY TYPE, 2021-2028 (USD MILLION)
TABLE 126 UK: BLOOD CULTURE TESTS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 127 UK: BLOOD CULTURE TESTS MARKET, BY END USER, 2021-2028 (USD MILLION)
TABLE 128 FRANCE: BLOOD CULTURE TESTS MARKET, BY METHOD, 2021-2028 (USD MILLION)
TABLE 129 FRANCE: BLOOD CULTURE TESTS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
TABLE 130 FRANCE: BLOOD CULTURE TESTS MARKET FOR CONSUMABLES, BY TYPE, 2021-2028 (USD MILLION)
TABLE 131 FRANCE: BLOOD CULTURE MEDIA MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 132 FRANCE: BLOOD CULTURE TESTS MARKET FOR INSTRUMENTS, BY TYPE, 2021-2028 (USD MILLION)
TABLE 133 FRANCE: SUPPORTING LABORATORY EQUIPMENT MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 134 FRANCE: BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
TABLE 135 FRANCE: BLOOD CULTURE TESTS MARKET FOR MOLECULAR TECHNOLOGIES, BY TYPE, 2021-2028 (USD MILLION)
TABLE 136 FRANCE: BLOOD CULTURE TESTS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 137 FRANCE: BLOOD CULTURE TESTS MARKET, BY END USER, 2021-2028 (USD MILLION)
TABLE 138 ITALY: BLOOD CULTURE TESTS MARKET, BY METHOD, 2021-2028 (USD MILLION)
TABLE 139 ITALY: BLOOD CULTURE TESTS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
TABLE 140 ITALY: BLOOD CULTURE TESTS MARKET FOR CONSUMABLES, BY TYPE, 2021-2028 (USD MILLION)
TABLE 141 ITALY: BLOOD CULTURE MEDIA MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 142 ITALY: BLOOD CULTURE TESTS MARKET FOR INSTRUMENTS, BY TYPE, 2021-2028 (USD MILLION)
TABLE 143 ITALY: SUPPORTING LABORATORY EQUIPMENT MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 144 ITALY: BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
TABLE 145 ITALY: BLOOD CULTURE TESTS MARKET FOR MOLECULAR TECHNOLOGIES, BY TYPE, 2021-2028 (USD MILLION)
TABLE 146 ITALY: BLOOD CULTURE TESTS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 147 ITALY: BLOOD CULTURE TESTS MARKET, BY END USER, 2021-2028 (USD MILLION)
TABLE 148 SPAIN: BLOOD CULTURE TESTS MARKET, BY METHOD, 2021-2028 (USD MILLION)
TABLE 149 SPAIN: BLOOD CULTURE TESTS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
TABLE 150 SPAIN: BLOOD CULTURE TESTS MARKET FOR CONSUMABLES, BY TYPE, 2021-2028 (USD MILLION)
TABLE 151 SPAIN: BLOOD CULTURE MEDIA MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 152 SPAIN: BLOOD CULTURE TESTS MARKET FOR INSTRUMENTS, BY TYPE, 2021-2028 (USD MILLION)
TABLE 153 SPAIN: SUPPORTING LABORATORY EQUIPMENT MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 154 SPAIN: BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
TABLE 155 SPAIN: BLOOD CULTURE TESTS MARKET FOR MOLECULAR TECHNOLOGIES, BY TYPE, 2021-2028 (USD MILLION)
TABLE 156 SPAIN: BLOOD CULTURE TESTS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 157 SPAIN: BLOOD CULTURE TESTS MARKET, BY END USER, 2021-2028 (USD MILLION)
TABLE 158 REST OF EUROPE: BLOOD CULTURE TESTS MARKET, BY METHOD, 2021-2028 (USD MILLION)
TABLE 159 REST OF EUROPE: BLOOD CULTURE TESTS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
TABLE 160 REST OF EUROPE: BLOOD CULTURE TESTS MARKET FOR CONSUMABLES, BY TYPE, 2021-2028 (USD MILLION)
TABLE 161 REST OF EUROPE: BLOOD CULTURE MEDIA MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 162 REST OF EUROPE: BLOOD CULTURE TESTS MARKET FOR INSTRUMENTS, BY TYPE, 2021-2028 (USD MILLION)
TABLE 163 REST OF EUROPE: SUPPORTING LABORATORY EQUIPMENT MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 164 REST OF EUROPE: BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
TABLE 165 REST OF EUROPE: BLOOD CULTURE TESTS MARKET FOR MOLECULAR TECHNOLOGIES, BY TYPE, 2021-2028 (USD MILLION)
TABLE 166 REST OF EUROPE: BLOOD CULTURE TESTS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 167 REST OF EUROPE: BLOOD CULTURE TESTS MARKET, BY END USER, 2021-2028 (USD MILLION)
TABLE 168 ASIA PACIFIC: BLOOD CULTURE TESTS MARKET, BY COUNTRY, 2021-2028 (USD MILLION)
TABLE 169 ASIA PACIFIC: BLOOD CULTURE TESTS MARKET, BY METHOD, 2021-2028 (USD MILLION)
TABLE 170 ASIA PACIFIC: BLOOD CULTURE TESTS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
TABLE 171 ASIA PACIFIC: BLOOD CULTURE TESTS MARKET FOR CONSUMABLES, BY TYPE, 2021-2028 (USD MILLION)
TABLE 172 ASIA PACIFIC: BLOOD CULTURE MEDIA MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 173 ASIA PACIFIC: BLOOD CULTURE TESTS MARKET FOR INSTRUMENTS, BY TYPE, 2021-2028 (USD MILLION)
TABLE 174 ASIA PACIFIC: SUPPORTING LABORATORY EQUIPMENT MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 175 ASIA PACIFIC: BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
TABLE 176 ASIA PACIFIC: BLOOD CULTURE TESTS MARKET FOR MOLECULAR TECHNOLOGIES, BY TYPE, 2021-2028 (USD MILLION)
TABLE 177 ASIA PACIFIC: BLOOD CULTURE TESTS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 178 ASIA PACIFIC: BLOOD CULTURE TESTS MARKET, BY END USER, 2021-2028 (USD MILLION)
TABLE 179 JAPAN: BLOOD CULTURE TESTS MARKET, BY METHOD, 2021-2028 (USD MILLION)
TABLE 180 JAPAN: BLOOD CULTURE TESTS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
TABLE 181 JAPAN: BLOOD CULTURE TESTS MARKET FOR CONSUMABLES, BY TYPE, 2021-2028 (USD MILLION)
TABLE 182 JAPAN: BLOOD CULTURE MEDIA MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 183 JAPAN: BLOOD CULTURE TESTS MARKET FOR CONSUMABLES, BY TYPE, 2021-2028 (USD MILLION)
TABLE 184 JAPAN: SUPPORTING LABORATORY EQUIPMENT MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 185 JAPAN: BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
TABLE 186 JAPAN: BLOOD CULTURE TESTS MARKET FOR MOLECULAR TECHNOLOGIES, BY TYPE, 2021-2028 (USD MILLION)
TABLE 187 JAPAN: BLOOD CULTURE TESTS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 188 JAPAN: BLOOD CULTURE TESTS MARKET, BY END USER, 2021-2028 (USD MILLION)
TABLE 189 CHINA: BLOOD CULTURE TESTS MARKET, BY METHOD, 2021-2028 (USD MILLION)
TABLE 190 CHINA: BLOOD CULTURE TESTS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
TABLE 191 CHINA: BLOOD CULTURE TESTS MARKET FOR CONSUMABLES, BY TYPE, 2021-2028 (USD MILLION)
TABLE 192 CHINA: BLOOD CULTURE MEDIA MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 193 CHINA: BLOOD CULTURE TESTS MARKET FOR INSTRUMENTS, BY TYPE, 2021-2028 (USD MILLION)
TABLE 194 CHINA: SUPPORTING LABORATORY EQUIPMENT MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 195 CHINA: BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
TABLE 196 CHINA: BLOOD CULTURE TESTS MARKET FOR MOLECULAR TECHNOLOGIES, BY TYPE, 2021-2028 (USD MILLION)
TABLE 197 CHINA: BLOOD CULTURE TESTS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 198 CHINA: BLOOD CULTURE TESTS MARKET, BY END USER, 2021-2028 (USD MILLION)
TABLE 199 INDIA: BLOOD CULTURE TESTS MARKET, BY METHOD, 2021-2028 (USD MILLION)
TABLE 200 INDIA: BLOOD CULTURE TESTS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
TABLE 201 INDIA: BLOOD CULTURE TESTS MARKET FOR CONSUMABLES, BY TYPE, 2021-2028 (USD MILLION)
TABLE 202 INDIA: BLOOD CULTURE MEDIA MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 203 INDIA: BLOOD CULTURE TESTS MARKET FOR INSTRUMENTS, BY TYPE, 2021-2028 (USD MILLION)
TABLE 204 INDIA: SUPPORTING LABORATORY EQUIPMENT MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 205 INDIA: BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
TABLE 206 INDIA: BLOOD CULTURE TESTS MARKET FOR MOLECULAR TECHNOLOGIES, BY TYPE, 2021-2028 (USD MILLION)
TABLE 207 INDIA: BLOOD CULTURE TESTS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 208 INDIA: BLOOD CULTURE TESTS MARKET, BY END USER, 2021-2028 (USD MILLION)
TABLE 209 REST OF ASIA PACIFIC: BLOOD CULTURE TESTS MARKET, BY METHOD, 2021-2028 (USD MILLION)
TABLE 210 REST OF ASIA PACIFIC: BLOOD CULTURE TESTS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
TABLE 211 REST OF ASIA PACIFIC: BLOOD CULTURE TESTS MARKET FOR CONSUMABLES, BY TYPE, 2021-2028 (USD MILLION)
TABLE 212 REST OF ASIA PACIFIC: BLOOD CULTURE MEDIA MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 213 REST OF ASIA PACIFIC: BLOOD CULTURE TESTS MARKET FOR INSTRUMENTS, BY TYPE, 2021-2028 (USD MILLION)
TABLE 214 REST OF ASIA PACIFIC: SUPPORTING LABORATORY EQUIPMENT MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 215 REST OF ASIA PACIFIC: BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
TABLE 216 REST OF ASIA PACIFIC: BLOOD CULTURE TESTS MARKET FOR MOLECULAR TECHNOLOGIES, BY TYPE, 2021-2028 (USD MILLION)
TABLE 217 REST OF ASIA PACIFIC: BLOOD CULTURE TESTS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 218 REST OF ASIA PACIFIC: BLOOD CULTURE TESTS MARKET, BY END USER, 2021-2028 (USD MILLION)
TABLE 219 LATIN AMERICA: BLOOD CULTURE TESTS MARKET, BY METHOD, 2021-2028 (USD MILLION)
TABLE 220 LATIN AMERICA: BLOOD CULTURE TESTS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
TABLE 221 LATIN AMERICA: BLOOD CULTURE TESTS MARKET FOR CONSUMABLES, BY TYPE, 2021-2028 (USD MILLION)
TABLE 222 LATIN AMERICA: BLOOD CULTURE MEDIA MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 223 LATIN AMERICA: BLOOD CULTURE TESTS MARKET FOR INSTRUMENTS, BY TYPE, 2021-2028 (USD MILLION)
TABLE 224 LATIN AMERICA: SUPPORTING LABORATORY EQUIPMENT MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 225 LATIN AMERICA: BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
TABLE 226 LATIN AMERICA: BLOOD CULTURE TESTS MARKET FOR MOLECULAR TECHNOLOGIES, BY TYPE, 2021-2028 (USD MILLION)
TABLE 227 LATIN AMERICA: BLOOD CULTURE TESTS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 228 LATIN AMERICA: BLOOD CULTURE TESTS MARKET, BY END USER, 2021-2028 (USD MILLION)
TABLE 229 MIDDLE EAST & AFRICA: BLOOD CULTURE TESTS MARKET, BY METHOD, 2021-2028 (USD MILLION)
TABLE 230 MIDDLE EAST & AFRICA: BLOOD CULTURE TESTS MARKET, BY PRODUCT, 2021-2028 (USD MILLION)
TABLE 231 MIDDLE EAST & AFRICA: BLOOD CULTURE TESTS MARKET FOR CONSUMABLES, BY TYPE, 2021-2028 (USD MILLION)
TABLE 232 MIDDLE EAST & AFRICA: BLOOD CULTURE MEDIA MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 233 MIDDLE EAST & AFRICA: BLOOD CULTURE TESTS MARKET FOR INSTRUMENTS, BY TYPE, 2021-2028 (USD MILLION)
TABLE 234 MIDDLE EAST & AFRICA: SUPPORTING LABORATORY EQUIPMENT MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 235 MIDDLE EAST & AFRICA: BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY, 2021-2028 (USD MILLION)
TABLE 236 MIDDLE EAST & AFRICA: MOLECULAR TECHNOLOGIES MARKET, BY TYPE, 2021-2028 (USD MILLION)
TABLE 237 MIDDLE EAST & AFRICA: BLOOD CULTURE TESTS MARKET, BY APPLICATION, 2021-2028 (USD MILLION)
TABLE 238 MIDDLE EAST & AFRICA: BLOOD CULTURE TESTS MARKET, BY END USER, 2021-2028 (USD MILLION)
TABLE 239 MAJOR STRATEGIES ADOPTED BY KEY PLAYERS IN BLOOD CULTURE TESTS MARKET
TABLE 240 BLOOD CULTURE TESTS MARKET: DEGREE OF COMPETITION
TABLE 241 BLOOD CULTURE TESTS MARKET: COMPANY FOOTPRINT ANALYSIS
TABLE 242 BLOOD CULTURE TESTS MARKET: METHOD FOOTPRINT ANALYSIS
TABLE 243 BLOOD CULTURE TESTS MARKET: PRODUCT FOOTPRINT ANALYSIS
TABLE 244 BLOOD CULTURE TESTS MARKET: TECHNOLOGY FOOTPRINT ANALYSIS
TABLE 245 BLOOD CULTURE TESTS MARKET: APPLICATION FOOTPRINT ANALYSIS
TABLE 246 BLOOD CULTURE TESTS MARKET: END USER FOOTPRINT ANALYSIS
TABLE 247 BLOOD CULTURE TESTS MARKET: REGIONAL FOOTPRINT ANALYSIS
TABLE 248 KEY PRODUCT LAUNCHES AND APPROVALS (JANUARY 2020-JULY 2023)
TABLE 249 KEY DEALS (JANUARY 2020-JULY 2023)
TABLE 250 BECTON, DICKINSON AND COMPANY: COMPANY OVERVIEW
TABLE 251 BIOMERIEUX: COMPANY OVERVIEW
TABLE 252 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
TABLE 253 DANAHER: COMPANY OVERVIEW
TABLE 254 LUMINEX CORPORATION: COMPANY OVERVIEW
TABLE 255 BRUKER: COMPANY OVERVIEW
TABLE 256 ROCHE DIAGNOSTICS: COMPANY OVERVIEW
TABLE 257 IRIDICA: COMPANY OVERVIEW
TABLE 258 T2 BIOSYSTEMS, INC.: COMPANY OVERVIEW
TABLE 259 BINDER GMBH: COMPANY OVERVIEW
TABLE 260 BIOBASE BIOTECH (JINAN) CO., LTD.: COMPANY OVERVIEW
TABLE 261 SCENKER BIOLOGICAL TECHNOLOGY CO., LTD.: COMPANY OVERVIEW
TABLE 262 BULLDOG BIO: COMPANY OVERVIEW
TABLE 263 ANAEROBE SYSTEMS, INC.: COMPANY OVERVIEW
TABLE 264 HIMEDIA LABORATORIES PVT. LTD.: COMPANY OVERVIEW
TABLE 265 AUTOBIO DIAGNOSTICS CO., LTD.: COMPANY OVERVIEW
TABLE 266 AXIOM LABORATORIES: COMPANY OVERVIEW
TABLE 267 MIKROSCAN TECHNOLOGIES, INC.: COMPANY OVERVIEW
TABLE 268 LABOTRONICS LTD.: COMPANY OVERVIEW
TABLE 269 HARDY DIAGNOSTICS: COMPANY OVERVIEW

LIST OF FIGURES (43 FIGURES)
FIGURE 1 RESEARCH DESIGN
FIGURE 2 PRIMARY SOURCES
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
FIGURE 4 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
FIGURE 5 SEGMENTAL EXTRAPOLATION: GLOBAL BLOOD CULTURE TESTS MARKET (2022)
FIGURE 6 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2023-2028)
FIGURE 7 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
FIGURE 8 MARKET DATA TRIANGULATION METHODOLOGY
FIGURE 9 BLOOD CULTURE TESTS MARKET, BY METHOD, 2023 VS. 2028 (USD MILLION)
FIGURE 10 BLOOD CULTURE TESTS MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION)
FIGURE 11 BLOOD CULTURE TESTS MARKET, BY TECHNOLOGY, 2023 VS. 2028 (USD MILLION)
FIGURE 12 BLOOD CULTURE TESTS MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)
FIGURE 13 BLOOD CULTURE TESTS MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
FIGURE 14 GEOGRAPHICAL SNAPSHOT OF BLOOD CULTURE TESTS MARKET
FIGURE 15 GROWING INCIDENCE OF SEPSIS CASES AND HIGH COST OF TREATMENT TO DRIVE MARKET
FIGURE 16 CONSUMABLES SEGMENT TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
FIGURE 17 CONVENTIONAL/MANUAL BLOOD CULTURE SEGMENT ACCOUNTED FOR LARGEST SHARE OF ASIA PACIFIC BLOOD CULTURE TESTS MARKET IN 2022
FIGURE 18 CHINA TO REGISTER HIGHEST GROWTH RATE DURING STUDY PERIOD
FIGURE 19 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATE DURING FORECAST PERIOD
FIGURE 20 BLOOD CULTURE TESTS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 21 MAJOR VALUE ADDED DURING MANUFACTURING AND ASSEMBLY PHASES
FIGURE 22 SUPPLY CHAIN ANALYSIS: BLOOD CULTURE TESTS MARKET
FIGURE 23 ECOSYSTEM MAPPING: BLOOD CULTURE TESTS MARKET
FIGURE 24 PATENT PUBLICATION TRENDS (JANUARY 2011-JUNE 2023)
FIGURE 25 TOP APPLICANTS (COMPANIES/INSTITUTIONS) FOR BLOOD CULTURE TEST PATENTS (JANUARY 2011-JUNE 2023)
FIGURE 26 TOP APPLICANTS FOR BLOOD CULTURE TEST PATENTS (COUNTRY/REGION) (JANUARY 2011-JULY 2023)
FIGURE 27 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS IN BLOOD CULTURE TESTS MARKET
FIGURE 28 KEY BUYING CRITERIA FOR BLOOD CULTURE TEST METHODS
FIGURE 29 NORTH AMERICA: BLOOD CULTURE TESTS MARKET SNAPSHOT
FIGURE 30 ASIA PACIFIC: BLOOD CULTURE TESTS MARKET SNAPSHOT
FIGURE 31 BLOOD CULTURE TESTS MARKET: REVENUE SHARE ANALYSIS OF MAJOR PLAYERS
FIGURE 32 BLOOD CULTURE TESTS MARKET SHARE ANALYSIS, BY KEY PLAYER (2022)
FIGURE 33 BLOOD CULTURE TESTS MARKET: COMPANY EVALUATION MATRIX FOR KEY PLAYERS (2022)
FIGURE 34 BLOOD CULTURE TESTS MARKET: COMPANY EVALUATION MATRIX FOR START-UPS/SMES (2022)
FIGURE 35 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2022)
FIGURE 36 BIOMERIEUX: COMPANY SNAPSHOT (2022)
FIGURE 37 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2022)
FIGURE 38 DANAHER: COMPANY SNAPSHOT (2022)
FIGURE 39 LUMINEX CORPORATION: COMPANY SNAPSHOT (2022)
FIGURE 40 BRUKER: COMPANY SNAPSHOT (2022)
FIGURE 41 ROCHE DIAGNOSTICS: COMPANY SNAPSHOT (2022)
FIGURE 42 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2022)
FIGURE 43 T2 BIOSYSTEMS, INC.: COMPANY SNAPSHOT (2022)